Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 49.50
+0.60 (1.23%)
May 5, 2026, 1:10 PM CET
Nolato AB Revenue
In the year 2025, Nolato AB had annual revenue of 9.46B SEK, down -2.09%. Nolato AB had revenue of 2.27B in the quarter ending December 31, 2025, a decrease of -4.62%.
Revenue
9.46B
Revenue Growth
-2.09%
P/S Ratio
1.39
Revenue / Employee
1.77M
Employees
5,343
Market Cap
13.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.46B | -202.00M | -2.09% |
| Dec 31, 2024 | 9.66B | 118.00M | 1.24% |
| Dec 31, 2023 | 9.55B | -1.23B | -11.40% |
| Dec 31, 2022 | 10.77B | -836.00M | -7.20% |
| Dec 31, 2021 | 11.61B | 2.25B | 24.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Elekta AB | 17.11B |
| Sectra AB | 3.52B |
| Vitrolife AB | 3.41B |
| MedCap AB | 2.18B |
| BICO Group AB | 1.49B |
| Xvivo Perfusion AB | 834.53M |
| CellaVision AB | 730.59M |
Nolato AB News
- 3 months ago - Nolato AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Nolato AB Earnings Call Transcript: Q3 2025 - Transcripts
- 10 months ago - Nolato AB Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Nolato AB Earnings Call Transcript: Q1 2025 - Transcripts